InsiderClue
Insiders · Profile

Lackner Mark

Chief Scientific Officer at Zentalis Pharmaceuticals · SVP, Head of Biology at IDEAYA Biosciences. Filing since 2 Jun 2020. CIK 0001777413

ZNTL Zentalis Pharmaceuticals, Inc. Chief Scientific Officer · 3 trades IDYA IDEAYA Biosciences, Inc. SVP, Head of Biology · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZNTL Zentalis Pharmaceuticals, Inc.
3 Feb 2025
Chief Scientific Officer
Sold at will
14,368
$24.59K
2.7%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Jan 2025
Chief Scientific Officer
Sold at will
4,411
$13.76K
2.3%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Feb 2024
Chief Scientific Officer
Sold at will
1,585
$18.29K
0.8%
IDYA IDEAYA Biosciences, Inc.
10 Feb 2021
SVP, Head of Biology
Sold, plan not stated
596
$12.52K
100%
IDYA IDEAYA Biosciences, Inc.
9 Feb 2021
SVP, Head of Biology
Sold, plan not stated
1,104
$23.23K
100%
IDYA IDEAYA Biosciences, Inc.
8 Feb 2021
SVP, Head of Biology
Sold, plan not stated
300
$6.30K
100%
IDYA IDEAYA Biosciences, Inc.
26 Jan 2021
SVP, Head of Biology
Sold, plan not stated
2,501
$46.16K
100%
IDYA IDEAYA Biosciences, Inc.
17 Jun 2020
SVP, Head of Biology
Sold, plan not stated
373
$7.43K
100%
IDYA IDEAYA Biosciences, Inc.
16 Jun 2020
SVP, Head of Biology
Sold, plan not stated
6,750
$100.76K
100%
IDYA IDEAYA Biosciences, Inc.
2 Jun 2020
SVP, Head of Biology
Sold, plan not stated
845
$7.78K
100%
10 decisions on file.